Coenzyme Q10 be measured in blood plasma, these measurements reflect dietary intake rather than tissue status. Currently, most clinical centers measure CoQ levels in cultured skin fibroblasts, muscle biopsies, and blood mononuclear cells. Culture fibroblasts can be used also to evaluate the rate of endogenous CoQ biosynthesis, by measuring the uptake of C-labelled "p"-hydroxybenzoate. CoQ shares a biosynthetic pathway with cholesterol. The synthesis of an intermediary precursor of CoQ, mevalonate, is inhibited by some beta blockers, blood pressure-lowering medication, and statins, a class of cholesterol-lowering drugs. Statins can reduce serum levels of CoQ by up to 40%. CoQ is not approved by
Biodiversity and drugs example, caffeine, methyl salicylate and quinine. Streptomycin, neomycin, and erythromycin are derived from tropical soil fungi. A lot of plant species are used in today's studies and have been exhaustively studied for their potential value as source of drugs. It is possible that some plant species may be a source of drugs against high blood pressure, AIDS or heart troubles. In China, Japan, India and Germany, there is a great deal of interest in and support for the search for new drugs from higher plants. Each species carries unique genetic material in its DNA and in its chemical factory responding